Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00302471
First received: March 9, 2006
Last updated: April 24, 2015
Last verified: April 2015